Research and Markets (http://www.researchandmarkets.com/research/vl56hm/vd_in_singapore)
has announced the addition of the "VD
in Singapore and Malaysia" report to their offering.
IVD manufacturers seeking marginal growth are focusing on regional
markets. The whole of Southeast Asia represents a unique opportunity for
healthcare providers and their various industry suppliers, including the
in vitro diagnostics (IVD) industry. In this report two nations are
detailed that are expected to provide opportunity for IVD manufacturers:
Singapore and Malaysia.
The nexus of regional trade, and a leading port and center for the
entire Asia-Pacific, is Singapore. The city-state features the most
developed and highest rated healthcare system in Southeast Asia and
serves as the headquarters and regional manufacturing center for some
medical device, biotechnology, IVD, and pharmaceutical companies.
Its neighbor Malaysia, an upper middle-income nation has arguably the
second-most developed healthcare system in Southeast Asia. Through
Singapore or Kuala Lumur, IVD companies have access to approximately 35
million potential patients, over 700,000 annual medical tourists, and
healthcare systems with higher per capita spending than anywhere else in
Southeast Asia or anywhere in Asia outside of Japan, Australia, or
Korea. Singapore and Malaysia present IVD markets and opportunities with
healthy prospects and solid fundaments in clinical demand.
This IVD in Singapore and Malaysia report contains the following
Key Topics Covered:
Chapter One: Introduction
Chapter Two: IVD Market Analysis
Chapter Three: IVD Companies And Market Leaders
For more information visit http://www.researchandmarkets.com/research/vl56hm/vd_in_singapore
[ Back To NFVZone's Homepage ]